Spinogenix - Crunchbase Company Profile & Funding

Q: Who invested in Spinogenix?

Spinogenix has 2 investors including U.S. Department of Defense And National Institutes of Health.

Q: When was the last funding round for Spinogenix?

Spinogenix closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Spinogenix raised to date?

Spinogenix has raised obfuscated.

Overview

Spinogenix

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Spinogenix

CB Rank

15491

Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.

Founded

obfuscation

Private

Venture - Series Unknown

San Diego, California, United States

1-10

www.spinogenix.com/

Biotechnology

Health Care

Medical

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Stella Sarraf: Founder
Stella Sarraf: President & CEO

Details

Legal Name

Spinogenix, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Stella Sarraf

About the Company

Spinogenix is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases. The company is focused on regenerating synapses to reverse declines in cognitive and motor function. They envision the use of SPGs as a monotherapy or in combination with other therapeutics that target disease-specific degenerative processes.

Spinogenix's mission is to create transformative therapeutics for diseases involving synaptic loss and dysfunction. It was founded in 2016 and is headquartered in San Diego, California.

Phone Number

858-263-3252

Contact Email

vince@spinogenix.com

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Insight

See this Growth Insight

Spinogenix is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

SPG302

A small molecule therapeutic designed to restore synapses and reverse cognitive and motor decline in neurodegenerative and neuropsychiatric diseases.

SPG601

A small molecule BK channel activator aimed at correcting synaptic dysfunction in Fragile X syndrome to address core symptoms.

Research & Development

Spinogenix is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Spinogenix	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spinogenix	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spinogenix	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spinogenix	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spinogenix	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Spinogenix	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spinogenix	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spinogenix	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spinogenix	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Spinogenix	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
U.S. Department of Defense	Yes	Grant - Spinogenix	—
U.S. Department of Defense	Yes	Grant - Spinogenix	—
U.S. Department of Defense	Yes	Grant - Spinogenix	—
U.S. Department of Defense	Yes	Grant - Spinogenix	—
U.S. Department of Defense	Yes	Grant - Spinogenix	—